CYRX — Cryoport, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1124524 ·
Last close
$14.93
Market Cap
$752.51M
52W High
$16.89
52W Low
$9.85
ADV30
739,418
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | — | — | — | — | — | — | — |
| Dec 2025 | 45,450,000 | 21,711,000 | -10,031,000 | -11,644,000 | 764,989,000 | 250,494,000 | 262,351,000 |
| Sep 2025 | 44,233,000 | 21,325,000 | -9,932,000 | -6,943,000 | 774,328,000 | 255,811,000 | 261,057,000 |
| Jun 2025 | 45,454,000 | 21,377,000 | -9,649,000 | 105,180,000 | 773,927,000 | 243,416,000 | 258,536,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-8,580,000
Investing CF
$250,323,000
Financing CF
$-21,074,000
CapEx
$-19,505,000
Dividends Paid
—
Buybacks
$-5,752,000
EPS Diluted TTM
$1.35
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-688,884,000
Inventory
$23,188,000
Receivables
$33,359,000
ST Investments
$160,714,000
EBIT TTM
$-32,099,000
Pretax Income TTM
$-34,460,000
Interest Exp TTM
$2,361,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$182,935,008
EBITDA
$-2,387,000
Free Cash Flow
$64,532,376
Enterprise Value
$643,797,440
Total Cash
$403,633,984
Total Debt
$230,488,992
Shares Out
50,402,313
Trailing EPS
$-0.90
Book Value
$8.98
ROE
-8.2%
ROA
-2.5%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 176,177,000 | -36,806,000 | 78,301,000 | 764,989,000 | 262,351,000 | — | -8,580,000 |
| Dec 2024 | 156,769,000 | -57,862,000 | -114,756,000 | 703,492,000 | 301,594,000 | — | -16,323,000 |
| Dec 2023 | 168,662,000 | -50,968,000 | -99,587,000 | 957,744,000 | 468,721,000 | — | -757,000 |
| Dec 2022 | 237,277,000 | -31,904,000 | -37,333,000 | 1,038,746,000 | 482,908,000 | — | -1,851,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.62
Max Pain — expiry 2026-12-18
max pain strike: $10.00 · spot: $15.09 · call oi: 8,121 · put oi: 1
Expected Move to 2026-12-18:
±$5.50
(36.45%) —
implied range
$9.59 –
$20.59
· ATM straddle on $15.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DSGN | Design Therapeutics, Inc. | $750.73M | $12.02 | — |
| PAHC | PHIBRO ANIMAL HEALTH CORP | $778.49M | $36.95 | — |
| RIGL | RIGEL PHARMACEUTICALS INC | $722.88M | $39.07 | — |
| MNPR | Monopar Therapeutics | $719.65M | $107.43 | — |
| ACRS | Aclaris Therapeutics, Inc. | $715.08M | $5.12 | — |
News headlines (Yahoo Finance, 1h cache)
Cryoport (CYRX) Stock Fair Value Rises After Analysts Lift Targets On Growth Trends
2026-07-27 05:06 · Yahoo
Cryoport to Report Second Quarter 2026 Financial Results on August 6, 2026
2026-07-23 12:00 · Yahoo
Cryoport's IntegriCell® Cryopreservation Services Selected by Verismo Therapeutics to Support Clinical KIR-CAR T Cell Therapy Programs
2026-06-25 12:00 · Yahoo
Cryoport (CYRX) Stock Fair Value Rises After Analysts Revisit Bioservices Outlook
2026-06-13 12:11 · Yahoo
Cryoport, Inc. Q1 2026 Earnings Call Summary
2026-05-05 00:23 · Yahoo
Cryoport (CYRX) Q1 2026 Earnings Transcript
2026-05-04 22:21 · Yahoo
CryoPort Q1 Earnings Call Highlights
2026-05-04 22:17 · Yahoo
CryoPort, Inc. (CYRX) Reports Q1 Loss, Tops Revenue Estimates
2026-05-04 21:50 · Yahoo
Cryoport (CYRX) Q2 2025 Earnings Transcript
2026-05-04 20:29 · Yahoo
Cryoport (CYRX) Q1 2025 Earnings Transcript
2026-05-04 20:28 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.